Investors are bracing for details as Mercedes-Benz prepares to release its full annual report, following disappointing preliminary figures. The focus has shifted squarely to the automaker’s strategy for recovery, questioning whether stringent cost-cutting and a wave of new models can offset significant weakness in China and contracting margins.
Financial Performance Reflects Operational Strain
The company’s fiscal year 2025 was marked by a severe downturn. Group net profit after tax plummeted by 48 percent to 5.33 billion euros. The decline was even more pronounced for the operating result (EBIT), which collapsed by 57 percent to 5.8 billion euros.
Market anxiety is palpable, reflected in a share price drop of approximately 2.9 percent to just over 55 euros. This weakness underscores the operational challenges the Stuttgart-based manufacturer faces. A primary driver of the slump is performance in its most critical single market: sales in China retreated by 19 percent, a particularly painful development given the group’s heavy reliance on this region. Additional headwinds came from tariffs amounting to roughly 1.2 billion US dollars and adverse currency effects.
Shareholder Returns and Outlook Diminished
Shareholders are feeling the direct impact. For the concluded fiscal year, management is proposing a reduced dividend of 3.50 euros per share, down from 4.30 euros the previous year. The guidance for 2026 has also dampened spirits. The targeted adjusted return on sales for the Cars division is set at 3 to 5 percent, notably below analyst expectations, which averaged 5.6 percent.
Strategic Countermeasures: Cost Cuts and Localization
In response, the board has mandated a strict efficiency program aimed at restoring profitability. The plan targets a 10 percent reduction in production costs per unit by 2027. One measure includes phasing out production at the Aguascalientes plant in Mexico. Concurrently, Mercedes-Benz is pushing a localization strategy, with plans to manufacture more than 80 percent of its vehicles for the Chinese market locally. This move is designed to lower expenses and mitigate tariff risks.
The company is also pinning hopes on what it calls the largest product offensive in its history. Over 40 new models are slated for launch within the next three years, intended to win back customers. This effort is supported by an ongoing share buyback program, for which up to 1.7 billion euros remains available in 2026.
The Path Forward
Tomorrow’s annual report will provide concrete details on the known burdens from Chinese sales and restructuring costs. However, the medium-term valuation of the stock will hinge on the execution of this new strategic direction. The efficacy of combining deep cost reductions with a major model rollout will become clearer when the company presents its quarterly figures on April 29, 2026.
